Dr. Ann W. Gramza, MD

Dr. Ann W. Gramza, MD

Dr. Ann W. Gramza, MD

Languages: English
Fax: (202) 444-1229

Contact this Provider:

Specialties
  • Hematology
  • Medical Oncology
Conditions I Treat
  • acinic cell cancer
  • adenocarcinoma of the head and neck
  • adrenal neoplasm
  • anaplastic cancer of thyroid
  • base of skull tumors
  • Show All
Procedures I Perform
  • chemoradiation
  • combined modality therapy
  • head and neck cancer care
About the Provider

Dr. Gramza is the medical oncology director of Head and Neck Cancer at Lombardi Comprehensive Cancer Center and the medical oncologist specializing in Head and Neck and Endocrine Cancers at the Washington Cancer Institute at MedStar Washington Hospital Center. At both institutions, Dr. Gramza uses the most current and successful therapies available for each patient's unique cancer, including referral to clinical trials.

Prior to joining Lombardi Comprehensive Cancer Center and the Washington Cancer Institute, Dr. Gramza was an intramural investigator in the Endocrine Oncology Branch of the National Cancer Institute (NCI), National Institutes of Health, where she developed new treatments for thyroid malignancies.

Previously, she was a staff physician at the Portland Veterans Administration (VA) Medical Center, and held a joint appointment as assistant professor and medical oncologist at Oregon Health & Science University (OHSU) and its Multidisciplinary Head and Neck Cancer Clinics, respectively.

Dr. Gramza has been principal investigator and co-investigator for multiple clinical studies involving targeted therapy for thyroid cancer and new therapies for head and neck cancers. She has also received many grants for translational research.

Dr. Gramza's Philosophy of Care

One of the important things about the head and neck cancer program at both MedStar Georgetown and the Hospital Center is its interdisciplinary and extremely well-organized approach. Head and neck cancer care and treatment requires a team of oncologists, head and neck surgeons, radiation oncologists and others working closely together to ensure the best possible patient outcome. The team's regular communication about our patients' care further strengthens our program.

I think about each patient's treatment as if I were thinking about cancer treatment for a close friend or family member. A big part of my job is to help my patients make educated decisions about their treatments. I offer my medical opinion, but also try to provide a holistic scenario for each patient that considers his or her lifestyle and preferences. I try to make recommendations that are comfortable and feel right for each individual. Particularly for an incurable cancer, I really focus on quality of life considerations throughout treatment. If the cancer is curable, I work as hard and as quickly as I can to get patients healthy and back to their support systems. I enjoy the continuity of care in my field caring for patients through the entire course of disease. Through research, there's always the chance for an outstanding result for the patient.

Education
  • Fellowship Program: Oregon Health & Science University (2007)
  • Fellowship Program: University of New Mexico (2004)
  • Residency Program: University of New Mexico (2003)
  • Medical School: Ohio State University College of Medicine (2000)
  • Board Certification: American Board of Internal Medicine, Hematology
Publications/Presentations

  • "Endocrine Malignancies," the George Washington University Medical Center Hematology and Medical Oncology Best Practices Program, Washington, D.C. August 2015
  • "Research Advances in Differentiated and Medullary Thyroid Cancer," International Thyroid Cancer Survivors' Conference, Philadelphia, PA, September 2013
  • "The Current Status of Molecular Targeted Therapeutics for the Treatment of Advanced Medullary Thyroid Cancer" International Thyroid Cancer Survivors' Conference, Philadelphia, PA, September 2013
  • "Quality of Life: The Role of Palliative Care in Thyroid Cancer," International Thyroid Cancer Survivors' Conference, Chicago, IL, October 2012
  • Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma, Thyroid. 2013

Insurance
Practice Locations
  • 110 Irving Street Northwest
    Room 2149
    Washington, DC 20010
    View Map

    Phone: (202) 877-6998

    Accepting New Patients
  • 3800 Reservoir Road Northwest
    Washington, DC 20007
    View Map

Member of Medical Staff
  • MedStar Georgetown University Hospital
  • MedStar Washington Hospital Center